Intuitive Surgical, Inc. $ISRG Shares Sold by Waterloo Capital L.P.

Waterloo Capital L.P. lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,008 shares of the medical equipment provider’s stock after selling 1,103 shares during the quarter. Waterloo Capital L.P.’s holdings in Intuitive Surgical were worth $1,792,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. Norges Bank acquired a new position in Intuitive Surgical in the second quarter valued at about $2,569,260,000. Rakuten Investment Management Inc. acquired a new stake in shares of Intuitive Surgical during the third quarter valued at about $388,436,000. Vanguard Group Inc. raised its stake in shares of Intuitive Surgical by 2.1% in the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after acquiring an additional 670,302 shares during the period. Jennison Associates LLC lifted its holdings in shares of Intuitive Surgical by 20.4% in the 2nd quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock worth $1,696,738,000 after acquiring an additional 528,359 shares during the last quarter. Finally, Bessemer Group Inc. lifted its holdings in shares of Intuitive Surgical by 89.3% in the 2nd quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after acquiring an additional 371,806 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $488.15 on Friday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $609.08. The company has a market cap of $173.36 billion, a P/E ratio of 61.87, a PEG ratio of 3.70 and a beta of 1.65. The firm has a fifty day moving average of $549.63 and a two-hundred day moving average of $510.54.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business’s revenue was up 18.8% compared to the same quarter last year. During the same quarter last year, the firm posted $2.21 EPS. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. UBS Group reaffirmed a “neutral” rating on shares of Intuitive Surgical in a research note on Thursday, January 15th. TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday, December 29th. Piper Sandler reissued an “overweight” rating and issued a $620.00 price objective (up previously from $610.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a research note on Friday, January 9th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $617.23.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Gary S. Guthart sold 2,800 shares of the stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $531.52, for a total transaction of $1,488,256.00. Following the transaction, the director owned 15,720 shares of the company’s stock, valued at $8,355,494.40. This trade represents a 15.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Henry L. Charlton sold 13,731 shares of the business’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the sale, the executive vice president owned 3,056 shares of the company’s stock, valued at $1,772,480. The trade was a 81.80% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 73,616 shares of company stock valued at $40,929,575. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.